Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEB071 dose-finding in plaque psoriasis
2007-007160-19Phase 2Completed
- Sponsor
- Novartis
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sotrastaurin in plaque psoriasis (6 arms), sponsored by Novartis. Primary endpoint: PASI75 treatment response. Started Jan 2009; status: completed.
02
Drugs
sotrastaurin
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2007-007160-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007160-19.